SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-207596
Filing Date
2021-07-02
Accepted
2021-07-02 16:07:33
Documents
4
Effectiveness Date
2021-07-02

Document Format Files

Seq Description Document Type Size
1 S-8 d133162ds8.htm S-8 46611
2 EX-5.1 d133162dex51.htm EX-5.1 5706
3 EX-23.1 d133162dex231.htm EX-23.1 1667
4 GRAPHIC g133162g0702002416496.jpg GRAPHIC 2418
  Complete submission text file 0001193125-21-207596.txt   58436
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257641 | Film No.: 211070024
SIC: 2834 Pharmaceutical Preparations